Tesaro Raises $60 Million in Series A Funding

Tesaro Inc., a Boston-based oncology pharma startup, has secured $60 million in Series A commitments led by New Enterprise Associates. The round includes an initial $20 million calldown and $40 million in capital reserves. Tesaro was founded by former executives with MGI Pharma, which was acquired by Eisai Co. in 2008 for $3.9 billion.

North AmericaUSBriefs